Lopinavir/Ritonavir 200mg/50mg Tablets (Alltera)

Inhibitor of the HIV-1 and HIV-2 proteases. Inhibition of HIV protease prevents cleavage of the gag-pol polyprotein resulting in the production of immature, non-infectious virus.

Share Now

Additional Information

NameLopinavir/Ritonavir
DescriptionInhibitor of the HIV-1 and HIV-2 proteases. Inhibition of HIV protease prevents cleavage of the gag-pol polyprotein resulting in the production of immature, non-infectious virus.
Active IngredientLopinavir/Ritonavir
Indication
  • A fixed dose combination medication for the treatment and prevention of Anti Retrovirals as well as HIV/AID.
  • World Health Organization’s List of Essential Medicines.
  • The safest and most effective medicines needed in a health system.
  • Was approved by the USFDA for the ARV/HIV/AIDs
  • When used on patients with Covid 19 they showed significant signs of improvement.
  • Being considered tested and used for the treatment of the emerging novel coronavirus (COVID-19)
  • Have fairly good inhibitory effects on SARS-CoV-2
  • A retrospective comparative analysis completed by the WHO has revealed that Lopinavir/Ritonavir was successful in acute respiratory distress syndrome or death reduction from 28% to 2.4%
Strengths200mg/50mg Tablets
Business PartnerMylan
OriginIndia

Related Products

Disclaimer

Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the  respective local health authority or contracted by the MAH to supply to the end users  on a named patient basis. Some products such  as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.

[elfsight_whatsapp_chat id='1']